TradingMenu expanded
Forge Markets Browse Companies
DataMenu expanded
Forge Data IPO Stock Tracker
SolutionsMenu expanded
For Institutions For Shareholders For Investors For Companies In Europe
InsightsMenu expanded
All Insights Blog Reports Videos Webinars
Popular Topics
Buying Pre-IPO Shares Selling Pre-IPO Shares Private Market Reports Private Market Data & Analytics Startup News
AboutMenu expanded
About Us Team Investor Relations People & Culture Careers FAQs
Log In Sign Up
Trading Menu expandedTrading
Forge Markets
Browse Companies
Data Menu expandedData
Forge Data
IPO Stock Tracker
Solutions Menu expandedSolutions
For Institutions
For Shareholders
For Investors
For Companies
In Europe
Insights Menu expandedInsights
All Insights
Blog
Reports
Videos
Webinars
Popular Topics
Buying Pre-IPO Shares
Selling Pre-IPO Shares
Private Market Reports
Private Market Data & Analytics
Startup News
About Menu expandedAbout
About Us
Team
Investor Relations
People & Culture
Careers
FAQs
Trading / Browse Companies / Recursion Pharmaceuticals Stock

Recursion Pharmaceuticals Stock

recursionpharma.comHealthcareFounded: 2013Funding to Date: $333.7MM

Recursion is a clinical-stage biotechnology company decoding biology by integrating technological innovations across biology, chemistry, automation, data science and engineering to industrialize drug discovery.

Learn more about Recursion Pharmaceuticals IPO
Register for Details

For more details on financing and valuation for Recursion Pharmaceuticals, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for Recursion Pharmaceuticals.

Register Today

Team

Management Team

Mason Victors
Chief Technology Officer & Chief Product Officer
Sharath Hegde
Chief Scientific Officer
Ronald Alfa Ph.D
Senior Vice President of Translational Discovery & Chief Evangelist
Blake Borgeson Ph.D
Co-Founder, Scientific Advisor & Board Member
Christopher Gibson Ph.D
Co-Founder, Chief Executive Officer & Board Member
Kevin Leggat
Controller
Kevin Lynch Ph.D
Chief Business Officer
Dean Li Ph.D
Board Member & Founder
Tina Larson
Chief Operating Officer
Ben Sukow
Director, Engineering
Heather Kirkby
Chief People Officer

Board Members

Blake Borgeson Ph.D
Zavain Dar
Lux Capital Management
Alaa Halawa
Mubadala Investment Company
Dean Li Ph.D
Zachary Bogue JD
Data Collective
Nan Li
Obvious Ventures
Christopher Gibson Ph.D
Reid Hutchins
Advantage Capital (Saint Louis)
Perry Fell Ph.D
James Hardiman
Data Collective

Other companies like Recursion Pharmaceuticals in the Healthcare sector

Neuralink
Sector
Healthcare
Last Round Est. Valuation
$2.15B
Colossal Biosciences
Sector
Healthcare
 
 
Altos Labs
Sector
Healthcare
Last Round Est. Valuation
$3.67B
Synchron
Sector
Healthcare
Last Round Est. Valuation
$400.53MM
Grail
Sector
Healthcare
Last Round Est. Valuation
$4.26B
OURA
Sector
Healthcare
 
 
Cytonics
Sector
Healthcare
 
 
Mammoth Biosciences
Sector
Healthcare
Last Round Est. Valuation
$1.08B
Precision Neuroscience
Sector
Healthcare
 
 

News

Crunchbase 09/09/2020
Recursion Gets Funding For New Drug Discovery With Bayer-led $239M Series D
The new investment provides Recursion with capital to further develop its drug discovery platform and pipeline.
MarketScreener 07/31/2019
Recursion : Appoints Heather Kirkby as Chief People Officer

Trending Companies

Frequently Asked Questions